Patrizio Lancellotti
Université de Liège
H-index: 132
Europe-Belgium
Top articles of Patrizio Lancellotti
Transcatheter aortic valve implantation versus surgical aortic valve replacement in severe aortic stenosis patients at low surgical mortality risk: a cost-effectiveness …
Acta Cardiologica
2024/1/2
Patrizio Lancellotti
H-Index: 99
Is transcatheter aortic valve implantation for aortic stenosis cost-effective?
Acta Cardiologica
2024/1/2
Patrizio Lancellotti
H-Index: 99
Vignette thérapeutique de l’étudiant. Patient avec un diabète de type 2, une coronaropathie et une insuffisance cardiaque.
Revue Médicale de Liège
2024
Patrizio Lancellotti
H-Index: 99
Design, manufacturing and testing of a green non-isocyanate polyurethane prosthetic heart valve
Biomaterials Science
2024
Patrizio Lancellotti
H-Index: 99
Cécile Oury
H-Index: 27
Le médicament du moisMavacamten (Camzyos®): premier inhibiteur réversible de l’ATP-ase de la myosine pour le traitement des cardiomyopathies hypertrophiques obstructives.
Revue Médicale de Liège
2024
Patrizio Lancellotti
H-Index: 99
Tricuspid regurgitation: Frequency, clinical presentation, management and outcome among patients with severe left‐sided valvular heart disease in Europe. Insights from the ESC …
European Journal of Heart Failure
2024/2/19
Editors’ highlight picks from 2023 in EHJ Open
2024/1
Design of 3D-Photoprintable, Bio-, and Hemocompatible Nonisocyanate Polyurethane Elastomers for Biomedical Implants
Biomacromolecules
2024/2/15
Patrizio Lancellotti
H-Index: 99
Cécile Oury
H-Index: 27
Acute and chronic coronary artery disease
2024/2/7
Patrizio Lancellotti
H-Index: 99
Mitral Regurgitation, The Left Atrium and Atrial Fibrillation: Unlikely Bedfellows or Natural Kindreds?
2024/2/2
Patrizio Lancellotti
H-Index: 99
Three-dimensional transoesophageal echocardiography: how to use and when to use-a clinical consensus statement from the European Association of Cardiovascular Imaging of the …
European Heart Journal-Cardiovascular Imaging
2023/8
Thor Edvardsen
H-Index: 65
Patrizio Lancellotti
H-Index: 99
The World Alliance of Societies of Echocardiography normative data on right ventricular motion components
European Heart Journal-Cardiovascular Imaging
2024/5
Patrizio Lancellotti
H-Index: 99
Mavacamten (Camzyos®): first myosin modulator for obstructive hypertrophic cardiomyopathy treatment
Revue Medicale de Liege
2024/2/1
Patrizio Lancellotti
H-Index: 99
Use of percutaneous ventricular assist device as bridge to high risk combined heart valve surgery
Acta Cardiologica
2024/4/5
Patrizio Lancellotti
H-Index: 99
Vincent Bonhomme
H-Index: 12
The WASE normative data on right ventricular motion components: where uniformity meets diversity!
2024/2
Patrizio Lancellotti
H-Index: 99
First-line treatment of hypercholesterolemia: start with statin monotherapy or ezetimibe-statin combination?
Revue Medicale de Liege
2024/4/1
Patrizio Lancellotti
H-Index: 99
Patient with type 2 diabetes and coronary heart disease developing heart failure
Revue Medicale de Liege
2024/4/1
Patrizio Lancellotti
H-Index: 99
Cardiac Damage and Conduction Disorders after Transcatheter Aortic Valve Implantation
Journal of Clinical Medicine
2024/1/11
Cécile Oury
H-Index: 27
Patrizio Lancellotti
H-Index: 99
Implications of Atrial Fibrillation for Guideline-Directed Therapy in Patients With Heart Failure: JACC State-of-the-Art Review
2024/3/5
Bridging perspectives from prevention, diagnosis, management to economic aspects: the voice of Belgian cardiologists
2024/1/2
Patrizio Lancellotti
H-Index: 99
